Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Abpro Holdings, Inc. (ABPO) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Abpro Holdings, Inc. (ABPO), most recent 12 months reported: net income $2.01M. Latest balance sheet on file: liquid cash $4.24M. From SEC filings. Others in Biological Products, (No Diagnostic Substances): INMUNE BIO INC. · Senti Biosciences Holdings, Inc. · Creative Medical Technology Holdings, Inc. · Acumen Pharmaceuticals, Inc. · AGENTIX CORP. · Allogene Therapeutics, Inc. · Adaptin Bio, Inc. · ARMATA PHARMACEUTICALS, INC.

Stock screener

Watchlist